Veraxa Biotech Holding AG (FRA:J8L0) PB Ratio: (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:J8L0 Veraxa Biotech Holding AG FRA:J8L0
13 GF Score
Price €1.62
! 2 Warning Signs
View Full Analysis

What is Veraxa Biotech Holding AG PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-01), Veraxa Biotech Holding AG's share price is €1.616. Veraxa Biotech Holding AG's Book Value per Share for the quarter that ended in Dec. 2025 was €-0.12. Hence, Veraxa Biotech Holding AG's PB Ratio of today is .

The historical rank and industry rank for Veraxa Biotech Holding AG's PB Ratio or its related term are showing as below:

FRA:J8L0's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.705
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, Veraxa Biotech Holding AG's average Book Value Per Share Growth Rate was -156.90% per year.

Back to Basics: PB Ratio


Veraxa Biotech Holding AG  (FRA:J8L0) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Veraxa Biotech Holding AG PB Ratio Related Terms


Veraxa Biotech Holding AG PB Ratio Historical Data

* Premium members only.

The historical data trend for Veraxa Biotech Holding AG's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veraxa Biotech Holding AG PB Ratio Chart

Veraxa Biotech Holding AG Annual Data
Trend Dec23 Dec24 Dec25
PB Ratio
0.00 0.00 0.00

Veraxa Biotech Holding AG Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
PB Ratio 0.00 0.00 0.00 0.00 0.00

FRA:J8L0 vs TTRX, IRD, IFRX: PB Ratio Comparison

For the Biotechnology subindustry, Veraxa Biotech Holding AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veraxa Biotech Holding AG PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veraxa Biotech Holding AG's PB Ratio distribution charts can be found below:

* The bar in red indicates where Veraxa Biotech Holding AG's PB Ratio falls into.


FRA:J8L0
13GF Score
Veraxa Biotech Holding AG FRA:J8L0
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veraxa Biotech Holding AG PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Veraxa Biotech Holding AG's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2025)
=1.616/-0.119
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Veraxa Biotech Holding AG Business Description

Other Exchanges VRXA:USA
Address Talacker 35, Zurich, CHE, 8001
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
13GF Score

Get the complete analysis for FRA:J8L0

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.62
Price